Showing results (1-10 of 214) with videos related to
Sort By:
Pageof 22
Blood Advances|April 27, 2021
Treating lymphoma is now a bit EZ-erRyan D Morin, Sarah E Arthur, Sarit AssoulineBritish Journal of Haematology|September 1, 2021
Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?Ryan D Morin, Sarah E Arthur, Daniel J HodsonExpert Review of Hematology|July 24, 2020
An evaluation of polatuzumab vedotin for the treatment of patients with diffuse large B-cell lymphomaMoneeza Walji, Sarit AssoulineExpert Review of Hematology|January 12, 2021
A review of FDA-approved acute myeloid leukemia therapies beyond '7 + 3'Alexandre Bazinet, Sarit AssoulineFuture Oncology (London, England)|October 26, 2023
Mosunetuzumab and the emerging role of T-cell-engaging therapy in follicular lymphomaSarah Matarasso, Sarit AssoulineExpert Review of Hematology|October 11, 2023
Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?David R Spillane, Sarit AssoulineClinical Chemistry|July 22, 2016
Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular LymphomaMiguel Alcaide, Stephen Yu, Kevin Bushell, et al.Canadian Liver Journal|August 22, 2022
Rituximab-induced autoimmune hepatitis: A case study and literature reviewPolymnia Galiatsatos, Sarit Assouline, Adrian Gologan, et al.Cancers|November 12, 2013
The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)Sarit Assouline, Eftihia Cocolakis, Katherine L B BordenCurrent Treatment Options in Oncology|May 2, 2020
PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in LymphomaVladimir Sapon-Cousineau, Sasha Sapon-Cousineau, Sarit AssoulinePageof 22